Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
EOG Resources
EOG
$71.4B
| $48.9M | 0.07% |
678,910
-85,476
| -11% | -$5.91M |
|
227
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $48.4M | 0.07% |
949,811
+177,300
| +23% | +$9.21M |
|
228
NVIDIA
NVDA
$5.3T
| $48.4M | 0.07% |
55,325,200
+38,759,920
| +234% | +$29.6M |
|
229
CALL
Occidental Petroleum
OXY
$56B
| $48M | 0.07% |
705,200
-198,937
| -22% | -$13.3M |
|
230
Las Vegas Sands
LVS
$29.9B
| $47.9M | 0.07% |
939,276
-58,227
| -6% | -$2.67M |
|
231
Halliburton
HAL
$27.1B
| $47.5M | 0.07% |
1,357,924
-865,241
| -39% | -$28.2M |
|
232
PUT
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$228M
| $47.4M | 0.07% |
2
+1
| +100% | +$46.1M |
|
233
iShares MSCI Japan ETF
EWJ
$22.5B
| $47.4M | 0.07% |
1,077,929
-994,422
| -48% | -$44.7M |
|
234
Morgan Stanley
MS
$336B
| $47M | 0.07% |
1,880,858
-220,030
| -10% | -$5.62M |
|
235
PUT
Citigroup
C
$224B
| $46.6M | 0.07% |
1,136,700
-108,500
| -9% | -$4.53M |
|
236
3M
MMM
$93.2B
| $46.6M | 0.07% |
335,730
-91,541
| -21% | -$11.8M |
|
237
American Electric Power
AEP
$68.2B
| $46.6M | 0.07% |
705,821
-23,975
| -3% | -$1.48M |
|
238
TC Energy
TRP
$66.6B
| $46.5M | 0.07% |
1,191,530
+144,160
| +14% | +$5.05M |
|
239
Adobe
ADBE
$103B
| $46.4M | 0.07% |
499,170
+181,284
| +57% | +$15.7M |
|
240
Teva Pharmaceuticals
TEVA
$40.6B
| $46.4M | 0.07% |
875,445
+115,072
| +15% | +$6.75M |
|
241
CALL
PepsiCo
PEP
$189B
| $46.2M | 0.07% |
453,300
+197,200
| +77% | +$19.5M |
|
242
CALL
Pfizer
PFE
$149B
| $46M | 0.07% |
1,671,328
-2,184,942
| -57% | -$62.4M |
|
243
PUT
American Airlines Group
AAL
$10.6B
| $45.8M | 0.07% |
1,117,400
-329,900
| -23% | -$13.3M |
|
244
CALL
Chevron
CVX
$371B
| $45.5M | 0.07% |
478,700
-117,600
| -20% | -$10.3M |
|
|
245
PUT
PepsiCo
PEP
$189B
| $45.1M | 0.07% |
442,200
+381,300
| +626% | +$37.7M |
|
|
DFS
246
DELISTED
Discover Financial Services
DFS
| $45.1M | 0.07% |
901,213
+55,529
| +7% | +$2.68M |
|
247
Eli Lilly
LLY
$1.06T
| $44.5M | 0.07% |
618,393
-22,446
| -4% | -$1.7M |
|
248
VanEck Gold Miners ETF
GDX
$25.6B
| $44.2M | 0.07% |
2,325,695
-437,483
| -16% | -$7.53M |
|
249
Thermo Fisher Scientific
TMO
$214B
| $44.2M | 0.07% |
313,188
-23,540
| -7% | -$3.15M |
|
|
BXLT
250
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $44M | 0.07% |
1,101,037
+93,932
| +9% | +$3.72M |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.